Tenapanor

(Ibsrela®)

Ibsrela®

Drug updated on 11/14/2023

Dosage FormTablet (oral: 50 mg)
Drug ClassSodium/hydrogen exchanger 3 inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.